Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
Dr. Phillip Frost’s , Opko Health (NYSE: OPK) , revealed that it agreed to pay $10 million for the Israeli Inspiro Medical, a next generation dry powder inhaler to treat respiratory disorders. The deal was announsed on April 17, but it didn’t disclose the price at that time. The aquisition is expected to close in the second quarter.
A recent Securities and Exchange Commission filing by Opko Health reviled that Opko would pay Inspiro’s owners $1 million in cash and $9 million in newly issued Opko stock.
At its current price of $8.31 per share, it would take 1.08 million in Opko stock to reach a $9 million value. according to Yahoo! Finance, the company has about 413 million shares outstanding.